Woodcock’s Message To OTC Industry: Innovation, Innovation, Innovation
This article was originally published in The Tan Sheet
Executive Summary
Across the board innovation ranging from manufacturing to Rx switch programs is necessary for the OTC industry to spur growth in the future, according to FDA Acting Deputy Commissioner for Operations Janet Woodcock, MD